Biotech Holders Trust | TalkMarkets

Latest Posts

How Are Biotech ETFs Reacting To These Q3 Earnings Releases?

Article By: Zacks Investment Research

Saturday, November 6, 2021 6:00 PM EDT

There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see if these will impact ETFs exposed to the space.

In this article: IBB, BBH, XBI Also: AMGN, BIIB, GILD

Read

Take A Look At The Top-Performing Biotech ETFs YTD

Article By: Zacks Investment Research

Saturday, October 2, 2021 3:14 PM EDT

The biotechnology sector has been grabbing the headlines on the new coronavirus vaccine and drug-related updates. The space has also kept its promise of generating returns, with the Nasdaq Biotechnology Index rising about 6.9% so far in 2021.

In this article: BIB, IBB, BBH, IEIH, IDNA Also: JNJ, PFE, MRNA, BNTX

Read

Biotech ETFs To Benefit From Latest Booster Update

Article By: Zacks Investment Research

Saturday, August 21, 2021 3:59 PM EDT

Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from Sept. 20 onward. Here's ETFs that may benefit.

In this article: IBB, BBH, FBT, XBI, BTEC Also: PFE, MRNA, BNTX

Read

Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates

Article By: Zacks Investment Research

Saturday, July 3, 2021 7:17 PM EDT

The competition to come up with a vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to Moderna.

In this article: IBB, BBH, MRNA, IDNA, GERM Also: AZN, PFE

Read